VolitionRx Limited to Host Third Quarter Earnings Call
VolitionRx Limited (NYSE AMERICAN: VNRX) is preparing to host a conference call aimed at discussing its financial and operational results for the third quarter of 2025. This call will take place on a day dedicated to sharing crucial insights and updates.
Conference Call Details
The call is scheduled for Friday, November 14 at 8:30 a.m. Eastern Time. This event is an opportunity for stakeholders to gain insights into the company's financial performance and future endeavors.
Joining the call will be key executives, including Louise Batchelor, Group Chief Marketing & Communications Officer, Cameron Reynolds, President and Group Chief Executive Officer, Dr. Jake Micallef, Chief Scientific Officer, and Terig Hughes, Group Chief Financial Officer. Each leader will contribute to a comprehensive update on recent achievements and upcoming milestones for Volition.
How to Participate
Participants in the U.S. and Canada can dial in toll-free at 1-877-407-9716. For those in the U.K., the toll-free number is 0 800 756 3429, and international callers can reach the call at 1-201-493-6779. Please note the conference ID for this event is 13757129.
Audio Webcast Availability
A live audio webcast will be accessible, allowing more individuals to join the conversation. Additionally, there will be a telephone replay available until November 28. Replay options include 1-844-512-2921 for U.S. and Canada callers, or 1-412-317-6671 for international participants, using the same conference ID.
About Volition
Volition is a pioneering multinational company dedicated to revolutionizing the field of epigenetics. The organization works tirelessly to enhance the lives of both humans and animals by improving early detection methods for diseases.
The company is focused on the development of innovative and affordable blood tests, which could be instrumental in detecting and monitoring various diseases, including cancer and conditions related to NETosis. The advancements in early disease detection could significantly enhance patient longevity and quality of life.
With a dynamic research and development base in Belgium, Volition also maintains offices in the U.S. and London, fostering innovation and collaboration across borders.
Media Inquiries
For further information regarding media inquiries, Louise Batchelor can be contacted at +44 (0)7557 774620. She is eager to address any questions surrounding the upcoming conference call and the company's overall mission.
Investor Relations Contact
Jeremy Feffer from LifeSci Advisors is available for investor relations inquiries at +1-212-915-2568. He plays a key role in facilitating communication between Volition and its investors, ensuring they remain informed about the company's progress and opportunities.
Frequently Asked Questions
What is the date of the earnings conference call?
The earnings conference call is scheduled for November 14, 2025.
Who will be hosting the call?
The call will be hosted by Louise Batchelor, alongside other key executives from Volition.
How can I join the conference call?
You can join the call via the toll-free numbers provided for the U.S., Canada, and the U.K., or through the international dial-in numbers.
What is the purpose of the earnings call?
The purpose is to discuss Volition's third quarter financial results and provide a business update.
Is there a way to access a replay of the call?
Yes, there will be a replay available until November 28, with specific call-in details provided for access.
